Product NDC: | 0173-0953 |
Proprietary Name: | ZOVIRAX |
Non Proprietary Name: | acyclovir |
Active Ingredient(s): | 200 mg/5mL & nbsp; acyclovir |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0953 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019909 |
Marketing Category: | NDA |
Start Marketing Date: | 19900402 |
Package NDC: | 0173-0953-96 |
Package Description: | 473 mL in 1 BOTTLE (0173-0953-96) |
NDC Code | 0173-0953-96 |
Proprietary Name | ZOVIRAX |
Package Description | 473 mL in 1 BOTTLE (0173-0953-96) |
Product NDC | 0173-0953 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | acyclovir |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 19900402 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | ACYCLOVIR |
Strength Number | 200 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |